Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cellular Signalling|June 19, 2021
Cysteine residues in the C-terminal tail of connexin32 regulate its traffickingAnuttoma Ray, Parmender P Mehta
Journal of Cell Science|January 24, 2018
Dileucine-like motifs in the C-terminal tail of connexin32 control its endocytosis and assembly into gap junctionsAnuttoma Ray, Parul Katoch, Nimansha Jain, et al.
Endocrine Reviews|February 23, 2008
Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapiesMurielle Mimeault, Parmender P Mehta, Ralph Hauke, et al.
Plos One|April 20, 2012
Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cellsLinda Kelsey, Parul Katoch, Kristen E Johnson, et al.
Cardiovascular Research|August 12, 2011
Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang IINeeru M Sharma, Hong Zheng, Parmender P Mehta, et al.
Plos One|September 5, 2014
Vitamin D3 regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cellsLinda Kelsey, Parul Katoch, Anuttoma Ray, et al.
Molecular Biology of the Cell|February 1, 2013
Phosphorylation on Ser-279 and Ser-282 of connexin43 regulates endocytosis and gap junction assembly in pancreatic cancer cellsKristen E Johnson, Shalini Mitra, Parul Katoch, et al.
Molecular Biology of the Cell|October 20, 2006
Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cellsShalini Mitra, Lakshmanan Annamalai, Souvik Chakraborty, et al.
The Journal of Biological Chemistry|September 3, 2002
Impaired trafficking of connexins in androgen-independent human prostate cancer cell lines and its mitigation by alpha-cateninRajgopal Govindarajan, Sumin Zhao, Xiao-Hong Song, et al.
Growth Factors (Chur, Switzerland)|March 28, 2008
Improvement of cytotoxic effects induced by mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascadesMurielle Mimeault, Parmender P Mehta, Ralph Hauke, et al.
Pageof 2